06-429-I Sigma-AldrichAnti-IGF-IRα subunit Antibody
This Anti-IGF-IRα subunit Antibody is validated for use in Western Blotting, Immunoprecipitation, Immunocytochemistry for the detection of IGF-IRα subunit.
More>> This Anti-IGF-IRα subunit Antibody is validated for use in Western Blotting, Immunoprecipitation, Immunocytochemistry for the detection of IGF-IRα subunit. Less<<Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H | WB, IP, ICC | Ch | Affinity Purified | Polyclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | Affinity Purified |
Presentation | Purified chicken polyclonal IgY antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
Packaging Information | |
---|---|
Material Size | 100 μg |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
06-429-I | 04055977182453 |
Documentation
Anti-IGF-IRα subunit Antibody Ficha datos de seguridad (MSDS)
Título |
---|
Anti-IGF-IRα subunit Antibody Certificados de análisis
Cargo | Número de lote |
---|---|
Anti-IGF-IRα subunit - 3268883 | 3268883 |
Anti-IGF-IRα subunit - 4045750 | 4045750 |
Anti-IGF-IRα subunit -Q2589621 | Q2589621 |
Anti-IGF-IRα subunit -Q2589625 | Q2589625 |
Folleto
Cargo |
---|
New Products Flyer- Vol 4 Signaling Feature- NEW! Phosphohistidine Antibody |
Licencias necesarias e Información técnica
Cargo |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |
Póster
Cargo |
---|
Post-Translational Modifications |